For decades, Escherichia coli and Saccharomyces cerevisiae have dominated industrial bioproduction. Yet Gram-positive bacteria—particularly actinomycetes ...
Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic ...
Last August, hundreds of scientists hailing from academia and the pharmaceutical industry gathered in Copenhagen for the 12th ...
T cells are specialized immune cells responsible for identifying and targeting infections. When the body experiences ...
The tumor microenvironment (TME) is one of the most formidable barriers to durable cancer immunotherapy. Far from being a passive bystander, the TME ...
A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...
Tissue epithelia maintain their lineage identity under normal conditions but occasionally undergo ‘reprogramming’ into ...
STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) today announced a partnership to ...
Tooth enamel is the hardest substance in the human body, yet once damaged, it cannot regenerate naturally. To overcome this ...
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...
The bacillus Calmette-Guérin (BCG) vaccine, commonly used against tuberculosis, changed how immune cells behaved and altered ...
Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results